SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000935836-16-000733
Filing Date
2016-02-12
Accepted
2016-02-12 13:21:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 tobira13ga2.htm SC 13G/A 49206
  Complete submission text file 0000935836-16-000733.txt   50974
Mailing Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-741-6625
Tobira Therapeutics, Inc. (Subject) CIK: 0001311596 (see all company filings)

IRS No.: 030422069 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87592 | Film No.: 161417281
SIC: 2834 Pharmaceutical Preparations

Mailing Address P.O. BOX 250 BEND OR 97709
Business Address P.O. BOX 250 BEND OR 97709 541-647-5664
STONEPINE CAPITAL, L.P. (Filed by) CIK: 0001370042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A